A material impact across various sectors From an investor perspective, the growing adoption of weight-loss drugs particularly GLP-1 therapies could have a material impact across a wide range of sectors and industries, creating both winners and losers
The GRADE assessment rated five outcomes (21%) as High, four (17%) as Moderate, 13 (54%) as Low, and two (8%) as Very Low
How does GHK-Cu affect inflammatory markers in the body
Notable findings include: In the SURMOUNT-1 trial of tirzepatide for the treatment of obesity, secondary findings showed improvements in the GLP-1 treatment group in systolic blood pressure (-7.2mm Hg), diastolic blood pressure (-4.8mm Hg), triglycerides (-24.8mg/dl), fasting insulin (-42.9mIU liter), and total cholesterol (-4.8mg/dl)
PMID: 147 DengJKTanY
it can also break down muscle tissue for energy